# Image-Guided Surgical and Pharmacotherapeutic Routines as Part of Diligent Medical Treatment
## 1 Introduction
In the next paragraphs, this recent literature will be presented to show the wealth of current activity on the subject. Regarding SI, many contributions have been proposed recently, see examples [1; 2; 3; 4; 5; 6; 7]. These selected examples of recent works show different interests of SI using MRI or USI. Two of them are reviews of state of the art MRI-guided robotic interventions. The other five concern different applications, myocardial perfusion without exogenous contrast agents, artificial intelligence-assisted ultrasound-guided robotic trans-carotid revascularization, MRI safety considerations for MRI-guided radiotherapy, intraoperative transapical cardiac MRI-guided intervention and MR conditional biopsy, and ablation needle tip artifacts. For research concerning imaging performance in general, see examples [8; 9; 10; 11; 12; 13]. These include different imaging of metastatic spinal cord compression, pediatric body imaging, MRI cephalometric, and muscle fatty infiltration. Artifacts in images due to incompatibility of external insertions were also investigated, see examples [14; 15; 16; 17; 18; 19; 20]. These concern artifacts mainly in MRI due to metals, MRI artifact, and evaluation of pre examination screening, effects of metallic biomaterial, metal-artifact reduction, imaging-phantom study, imaging for periprosthetic joint infection, off-resonance artifact correction, and metal artifacts from passive implants. Several studies on safety conditions related to imaging techniques are reported, e.g., [21; 22; 23; 24]. These concern safety in radiation therapy, radiofrequency-induced implant heating, active auditory implants, and metallic implants. New or improved designs of scanners are given in examples [25; 26; 27; 28; 29; 30; 31]. These improvements concern breast intervention robot, reducing MRI susceptibility artefacts in implants, hip arthroplasty implants with metal artifact correction, improving MR image quality in metallic implants, superconducting magnet designs and MRI accessibility, improved visualization in patients with implants, and 3D-printing techniques for optimized imaging compatibility. Numerous investigations have been carried out on MRI-compatible devices; see examples [32; 33; 34; 35; 36; 37; 38; 39; 40; 41]. These concern MRI-compatible devices in cardiac MRI, compatible fiber optic multi sensor, self-supervised reconstruction of gradient descent, safe robotic manipulator, compatible robots, compatible endonasal surgical robotic system, imaging-enhanced cranial neurosurgery, plastic piezoelectric motor stator, and compatible piezoelectric motors. Recent work considering RDD has been reported in the literature; see e.g., [42; 43; 44; 45; 46; 47; 48; 49; 50]. These regard USI-guided DD enhancement, microbubble-mediated USI DD, microneedle patches for DD, DD to cancer cells, spatial, temporal, and dose control of DD, nanoparticles-based strategies to improve the delivery of therapeutic RNA in precision oncology, nanoparticle-based delivery systems in pancreatic cancer, and nano-drug delivery system for cancer. Contributions on implanted technologies and their concerns could be found, e.g., in [51; 52; 53; 54; 55; 56; 57; 58; 59]. These concern artefacts of biodegradable magnesium-based implants, assessment of implant-related pain and dysfunction, cochlear implant positioning and MR imaging quality, adverse local tissue reactions near metal implants after total hip arthroplasty, metal artefact reduction sequences for a piezoelectric bone conduction implant, image quality and artifact reduction of a cochlear implant, MRI in patients with cardiac implantable electronic devices, and MRI artifacts caused by auditory implants. Implanted treatment structures might manage confined conduct MI-imbedded equipment. These structures employ RDD for nearby tissue containing a specified area.